Skip to main
USPH
USPH logo

USPH Stock Forecast & Price Target

USPH Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 25%
Buy 75%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

US Physical Therapy Inc. has demonstrated a solid financial performance, highlighted by a sequential commercial pricing increase of 2.2%, indicating consistent demand for its services despite minor regional challenges. Additionally, the company's Industrial Injury Prevention (IIP) revenue showed robust growth, achieving a 22.2% increase overall and an impressive 18.4% growth when excluding contributions from mergers and acquisitions. These metrics reflect the company's strong operational capabilities and market positioning, reinforcing a positive outlook for its future financial performance.

Bears say

US Physical Therapy Inc has experienced a 0.6% decline in key revenue metrics, which fell to $83.95 compared to $84.46 in the previous year, signaling potential instability in revenue generation. The company has faced continuous reimbursement cuts over the past five years, resulting in a total profitability headwind of $20 million, further straining financial performance. Additionally, expenses related to rent, clinic operations, and contract labor have increased to 20.2% of revenue, slightly exceeding previous estimates, indicating rising operational costs that may hinder profitability.

USPH has been analyzed by 4 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 75% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of U.S. Physical Therapy and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About U.S. Physical Therapy (USPH) Forecast

Analysts have given USPH a Buy based on their latest research and market trends.

According to 4 analysts, USPH has a Buy consensus rating as of Oct 15, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $110.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $110.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

U.S. Physical Therapy (USPH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.